Bernd Hentsch
Directeur/Membre du Conseil chez G2M Cancer Drugs AG
Postes actifs de Bernd Hentsch
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
G2M Cancer Drugs AG
 G2M Cancer Drugs AG Miscellaneous Commercial ServicesCommercial Services Part of Valerio Therapeutics SA, G2M Cancer Drugs AG is a German company that researches new anti-cancer therapeutics and develops selected late-stage products. The company is based in Frankfurt am Main, Germany. G2M Cancer Drugs was acquired by Topotarget A/S on March 01, 2005. | Directeur/Membre du Conseil | 01/01/2001 | - |
Historique de carrière de Bernd Hentsch
Anciens postes connus de Bernd Hentsch
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| 4SC AG | Corporate Officer/Principal | 11/05/2010 | - |
TopoTarget UK Ltd.
 TopoTarget UK Ltd. Drugstore ChainsRetail Trade TopoTarget UK Ltd. engages in the discovery and development of drugs and therapies to treat cancer. It develops anti-cancer drugs for molecular mechanisms associated with the cell cycle, chromatin control and DNA damage. The company was founded in 2002 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - | - |
Formation de Bernd Hentsch
| Julius-Maximilians-Universität Würzburg | Doctorate Degree |
Statistiques
Internationale
| Allemagne | 4 |
| Royaume-Uni | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 2 |
| Commercial Services | 2 |
| Retail Trade | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| 4SC AG | Health Technology |
| Entreprise privées | 2 |
|---|---|
G2M Cancer Drugs AG
G2M Cancer Drugs AG Miscellaneous Commercial ServicesCommercial Services Part of Valerio Therapeutics SA, G2M Cancer Drugs AG is a German company that researches new anti-cancer therapeutics and develops selected late-stage products. The company is based in Frankfurt am Main, Germany. G2M Cancer Drugs was acquired by Topotarget A/S on March 01, 2005. | Commercial Services |
TopoTarget UK Ltd.
TopoTarget UK Ltd. Drugstore ChainsRetail Trade TopoTarget UK Ltd. engages in the discovery and development of drugs and therapies to treat cancer. It develops anti-cancer drugs for molecular mechanisms associated with the cell cycle, chromatin control and DNA damage. The company was founded in 2002 and is headquartered in Oxford, the United Kingdom. | Retail Trade |
- Bourse
- Insiders
- Bernd Hentsch
- Expérience
